Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Practical Risk Score for EEG Seizures in Hospitalized Patients
Epilepsy/Clinical Neurophysiology (EEG)
S11 - (-)
002
Authors/Disclosures
Aaron F. Struck, MD
PRESENTER
The institution of Dr. Struck has received research support from Ceribell.
No disclosure on file
Andres Rodriguez-Ruiz, MD (Emory University) Dr. Rodriguez-Ruiz has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum. Dr. Rodriguez-Ruiz has stock in Lourbeth LLC.
Jong W. Lee, MD, PhD (Brigham and Women's Hospital) Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bigoen. Dr. Lee has received stock or an ownership interest from Soterya. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from Epilepsy Foundation. The institution of Dr. Lee has received research support from Engage Therapeutics. Dr. Lee has received personal compensation in the range of $5,000-$9,999 for serving as a Contract work with Bioserenity. Dr. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Contract work with Teladoc.
Suzette M. LaRoche, MD, FAAN (University of North Carolina) Dr. LaRoche has received intellectual property interests from a discovery or technology relating to health care. Dr. LaRoche has received publishing royalties from a publication relating to health care. Dr. LaRoche has a non-compensated relationship as a President with American Clinical Neurophysiology Society that is relevant to AAN interests or activities.
Lawrence J. Hirsch, MD, FAAN (Yale University Comprehensive Epilepsy Center) Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accure. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rafa Laboratories, Ltd. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a speaker with UCB.
Emily J. Gilmore, MD (Yale University School of Medicine) Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
No disclosure on file
Hiba A. Haider, MD Dr. Haider has received publishing royalties from a publication relating to health care. Dr. Haider has received publishing royalties from a publication relating to health care.
No disclosure on file
M. B. Westover, MD, PhD (MGH) Dr. Westover has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.